InsightfulValue
← Home

AbbVie
AbbVie

-13.15%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

AbbVie

πŸ“Š Get full analytics about AbbVie

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

Price
Live  
Overview
AbbVie is a global, research-driven biopharmaceutical company that was founded in 2013 when it spun off from Abbott Laboratories. The company's focus is on developing advanced therapies and medicines for conditions such as immunology, oncology, neuroscience, and virology.
Headquartered in North Chicago, Illinois, AbbVie employs approximately 48,000 people worldwide and operates in more than 75 countries. The company is dedicated to providing innovative, safe, and effective treatments for patients, and its products are available in over 170 countries.
AbbVie's mission is to discover and deliver breakthrough medicines that enable people to live better lives. The company's values include integrity, collaboration, innovation, and a commitment to patient well-being. AbbVie has a strong pipeline of medications in various stages of development, and the company invests heavily in research and development to bring new treatments to patients.
Some of AbbVie's notable products include Humira, the best-selling prescription medication in the world, used to treat autoimmune conditions such as rheumatoid arthritis and Crohn's disease, and Imbruvica, a targeted therapy for certain types of cancers. The company also has a portfolio of other medicines and treatments for conditions such as hepatitis C, multiple sclerosis, and Parkinson's disease.
AbbVie is committed to giving back to communities by supporting various charitable and scientific organizations. The company's philanthropic efforts focus on initiatives that align with its areas of expertise, such as healthcare, education, and environmental sustainability.
In addition to its focus on research and patient care, AbbVie is also committed to operating ethically and responsibly. The company has stated its commitment to reducing its environmental impact, promoting diversity and inclusion, and upholding rigorous ethical standards in all its operations.
Overall, AbbVie is a leading, globally recognized biopharmaceutical company with a strong portfolio and a commitment to making a positive impact in the world.
What is special about the company?
AbbVie

πŸ“ˆ Want to read more about AbbVie?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

VGhlcmUgYX JlIHNldmVy YWwgbm90ZX dvcnRoeSBh c3BlY3RzIG 9mIHRoZSBB YmJWaWUgY2 9tcGFueSB0 aGF0IG1ha2 UgaXQgc3Rh bmQgb3V0IG Zyb20gb3Ro ZXIgcGhhcm 1hY2V1dGlj YWwgY29tcG FuaWVzOjxi cj4xLiBGb2 N1cyBvbiBp bm5vdmF0aX ZlIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudDogQW JiVmllIHBs YWNlcyBhIH N0cm9uZyBl bXBoYXNpcy BvbiBkaXNj b3ZlcmluZy BhbmQgZGV2 ZWxvcGluZy BuZXcgdHJl YXRtZW50cy Bmb3IgY2hh bGxlbmdpbm cgaGVhbHRo IGNvbmRpdG lvbnMuIFRo ZSBjb21wYW 55IGludmVz dHMgaGVhdm lseSBpbiBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn QsIHdpdGgg YSBzaWduaW ZpY2FudCBw b3J0aW9uIG 9mIGl0cyBy ZXZlbnVlIG JlaW5nIGFs bG9jYXRlZC B0byB0aGlz IGFyZWEuPG JyPjIuIFN0 cm9uZyBwb3 J0Zm9saW8g b2YgbGVhZG luZyBtZWRp Y2luZXM6IE FiYlZpZSBo YXMgYSByb2 J1c3QgcG9y dGZvbGlvIG 9mIG1lZGlj aW5lcyB0aG F0IGFkZHJl c3MgYSBkaX ZlcnNlIHJh bmdlIG9mIG Rpc2Vhc2Vz LCBpbmNsdW RpbmcgaW1t dW5vbG9neS wgbmV1cm9s b2d5LCBvbm NvbG9neSwg YW5kIHZpcm 9sb2d5LiBN YW55IG9mIG l0cyBwcm9k dWN0cyBhcm UgY29uc2lk ZXJlZCBiZX N0LWluLWNs YXNzIGluIH RoZWlyIHJl c3BlY3Rpdm UgdGhlcmFw ZXV0aWMgYX JlYXMuPGJy PjMuIFN0cm 9uZyBwaXBl bGluZTogSW 4gYWRkaXRp b24gdG8gaX RzIGN1cnJl bnQgbGluZS BvZiBtZWRp Y2luZXMsIE FiYlZpZSBo YXMgYSBzdH JvbmcgcGlw ZWxpbmUgb2 YgcG90ZW50 aWFsIG5ldy B0cmVhdG1l bnRzLCB3aG ljaCBpdCBj b250aW51b3 VzbHkgZXZh bHVhdGVzIG ZvciB0aGVp ciBwb3Rlbn RpYWwgdG8g YWRkcmVzcy B1bm1ldCBt ZWRpY2FsIG 5lZWRzIGFu ZCBjcmVhdG UgdmFsdWUg Zm9yIHBhdG llbnRzLjxi cj40LiBDb2 1taXRtZW50 IHRvIHBhdG llbnQgY2Fy ZTogQWJiVm llIGlzIGNv bW1pdHRlZC B0byBtYWtp bmcgYSBtZW FuaW5nZnVs IGRpZmZlcm VuY2UgaW4g dGhlIGxpdm VzIG9mIHBh dGllbnRzIG J5IHByb3Zp ZGluZyBhY2 Nlc3MgdG8g aW5ub3ZhdG l2ZSBtZWRp Y2luZXMgYW 5kIHN1cHBv cnRpbmcgZG lzZWFzZSBl ZHVjYXRpb2 4gYW5kIGF3 YXJlbmVzcy Bwcm9ncmFt cy48YnI+NS 4gU3VzdGFp bmFiaWxpdH kgaW5pdGlh dGl2ZXM6IF RoZSBjb21w YW55IGhhcy BhIHN0cm9u ZyBmb2N1cy BvbiBzdXN0 YWluYWJpbG l0eSBhbmQg aGFzIGltcG xlbWVudGVk IHNldmVyYW wgaW5pdGlh dGl2ZXMgdG 8gcmVkdWNl IGVudmlyb2 5tZW50YWwg aW1wYWN0LC Bwcm9tb3Rl IGVtcGxveW VlIHdlbGwt YmVpbmcsIG FuZCBzdXBw b3J0IGxvY2 FsIGNvbW11 bml0aWVzLj xicj42LiBT dHJvbmcgZm luYW5jaWFs IHBlcmZvcm 1hbmNlOiBB YmJWaWUgaG FzIGNvbnNp c3RlbnRseS BkZWxpdmVy ZWQgc3Ryb2 5nIGZpbmFu Y2lhbCByZX N1bHRzLCB3 aXRoIGEgdH JhY2sgcmVj b3JkIG9mIH N1c3RhaW5h YmxlIGxvbm ctdGVybSBn cm93dGggYW 5kIHNoYXJl aG9sZGVyIH ZhbHVlIGNy ZWF0aW9uLj xicj43LiBH bG9iYWwgcH Jlc2VuY2U6 IEFiYlZpZS BvcGVyYXRl cyBpbiBtb3 JlIHRoYW4g MTc1IGNvdW 50cmllcyBh bmQgaGFzIG Egc3Ryb25n IGdsb2JhbC BwcmVzZW5j ZSwgd2hpY2 ggZW5hYmxl cyBpdCB0by ByZWFjaCBh IHdpZGUgcG F0aWVudCBw b3B1bGF0aW 9uIGFuZCBj b250cmlidX RlIHRvIGlt cHJvdmluZy BnbG9iYWwg aGVhbHRoIG 91dGNvbWVz Lg==
What the company's business model?
AbbVie

πŸ“ˆ Want to read more about AbbVie?

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QWJiVmllIG lzIGEgYmlv cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IGZv Y3VzZXMgb2 4gdGhlIGRl dmVsb3BtZW 50LCBtYW51 ZmFjdHVyaW 5nLCBhbmQg Y29tbWVyY2 lhbGl6YXRp b24gb2YgaW 5ub3ZhdGl2 ZSBwaGFybW FjZXV0aWNh bCBwcm9kdW N0cyBwcmlt YXJpbHkgaW 4gdGhlIGFy ZWFzIG9mIG ltbXVub2xv Z3ksIG9uY2 9sb2d5LCBu ZXVyb3NjaW VuY2UsIGFu ZCB2aXJvbG 9neS4gPGJy PlRoZSBjb2 1wYW55J3Mg YnVzaW5lc3 MgbW9kZWwg aXMgY2VudG VyZWQgYXJv dW5kIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCAo UiZEKSBvZi BuZXcgbWVk aWNpbmVzIG FuZCB0aGVy YXBpZXMsIH N0cmF0ZWdp YyBjb2xsYW JvcmF0aW9u cyBhbmQgcG FydG5lcnNo aXBzLCBhbm QgYSBzdHJv bmcgc2FsZX MgYW5kIG1h cmtldGluZy BzdHJhdGVn eSB0byBicm luZyB0aGVz ZSBwcm9kdW N0cyB0byBt YXJrZXQuID xicj5BYmJW aWUncyBSJk QgZWZmb3J0 cyBhcmUgZm 9jdXNlZCBv biBpZGVudG lmeWluZyBw b3RlbnRpYW wgdHJlYXRt ZW50cyBmb3 IgZGlzZWFz ZXMgd2l0aC B0aGUgZ3Jl YXRlc3QgdW 5tZXQgbmVl ZHMsIHVzaW 5nIGN1dHRp bmctZWRnZS B0ZWNobm9s b2dpZXMgYW 5kIGlubm92 YXRpdmUgYX Bwcm9hY2hl cy4gVGhlIG NvbXBhbnkg aGFzIGEgcm 9idXN0IHBp cGVsaW5lIG 9mIHByb21p c2luZyBkcn VnIGNhbmRp ZGF0ZXMgaW 4gdmFyaW91 cyBzdGFnZX Mgb2YgZGV2 ZWxvcG1lbn QuIDxicj5J biBhZGRpdG lvbiwgQWJi VmllIGhhcy Blc3RhYmxp c2hlZCBzdH JhdGVnaWMg Y29sbGFib3 JhdGlvbnMg YW5kIHBhcn RuZXJzaGlw cyB3aXRoIG xlYWRpbmcg b3JnYW5pem F0aW9ucyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeSB0byBj b21wbGVtZW 50IGl0cyBp bi1ob3VzZS BSJkQgZWZm b3J0cyBhbm QgYWR2YW5j ZSBpdHMgZH J1ZyBkaXNj b3ZlcnkgYW 5kIGRldmVs b3BtZW50IH Byb2dyYW1z LiBUaGlzIG luY2x1ZGVz IHBhcnRuZX JzaGlwcyB3 aXRoIGFjYW RlbWljIGlu c3RpdHV0aW 9ucywgYmlv dGVjaCBjb2 1wYW5pZXMs IGFuZCBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMuID xicj5BYmJW aWUgYWxzby BoYXMgYSBz dHJvbmcgc2 FsZXMgYW5k IG1hcmtldG luZyBzdHJh dGVneSB0by Bkcml2ZSB0 aGUgY29tbW VyY2lhbCBz dWNjZXNzIG 9mIGl0cyBw cm9kdWN0cy 4gVGhlIGNv bXBhbnkgaG FzIGEgZ2xv YmFsIHByZX NlbmNlIGFu ZCBhIGRpdm Vyc2lmaWVk IHBvcnRmb2 xpbyBvZiBk cnVncywgd2 hpY2ggYWxs b3dzIGl0IH RvIGxldmVy YWdlIGl0cy BvcGVyYXRp b25zIGFuZC ByZXNvdXJj ZXMgaW4gZG lmZmVyZW50 IG1hcmtldH MuIDxicj5P dmVyYWxsLC B0aGUgQWJi VmllIGJ1c2 luZXNzIG1v ZGVsIGlzIG ZvY3VzZWQg b24gZGV2ZW xvcGluZyBh bmQgYnJpbm dpbmcgaW5u b3ZhdGl2ZS BtZWRpY2lu ZXMgdG8gcG F0aWVudHMg aW4gbmVlZC wgd2hpbGUg YWxzbyBkcm l2aW5nIHBy b2ZpdGFibG UgZ3Jvd3Ro IHRocm91Z2 ggc291bmQg UiZELCBwYX J0bmVyc2hp cHMsIGFuZC Bjb21tZXJj aWFsaXphdG lvbiBzdHJh dGVnaWVzLg ==
Interesting facts about the company
AbbVie

πŸ“ˆ Want to read more about AbbVie?

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvWE E4UGdOTTI1 RTBlS3NEVW 1ySEQud2Vi cCIgYWx0PS JBYmJWaWUi IHRpdGxlPS JBYmJWaWUi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgQWJiVmll PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag4pyN77iP IFNpZ24gdX AgdG8gZ2V0 IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4gZm9y IGZyZWUKIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgCiAgIC AgICAgCiAg ICAgICAgPH NwYW4gY2xh c3M9J2JsdX JyZWQtdGV4 dCc+CiAgIC AgICAgICAg IE1TNGdRV0 ppVm0gbGxJ SGRoY3lCai BjbVZoZEdW a0lHIEZ6SU dFZ2MzQnAg Ym05bVppQm piMiAxd1lX NTVJR1p5IG IyMGdRV0pp YjMgUjBJRX hoWW05eSBZ WFJ2Y21sbG N5IEJwYmlB eU1ERXogTE NCdFlXdHBi bSBjZ2FYUW dZU0J5IFpX eGhkR2wyWl cgeDVJSGx2 ZFc1biBJR0 52YlhCaGJu IGtnWTI5dG NHRnkgWldR Z2RHOGdiMy BSb1pYSnpJ R2x1IElIUm 9aU0J3YUcg RnliV0ZqWl hWMCBhV05o YkNCcGJtIF IxYzNSeWVT NDggWW5JK0 1pNGdWRyBo bElHNWhiV1 VnIFFXSmlW bWxsSUcgbH pJR1JsY21s MiBaV1FnWm 5KdmJTIEJo SUdOdmJXSn AgYm1GMGFX OXVJRyA5bU lIUm9aU0Iz IGIzSmtjeU JCWW0gSnZk SFFnWVc1ay BJSFpwZEdG c2FYIFI1TG p4aWNqNHog TGlCQlltSl dhVyBYaWdK bHpJR2hsIF lXUnhkV0Z5 ZEcgVnljeU JoY21VZyBi RzlqWVhSbF pDIEJwYmlC T2IzSjAgYU NCRGFHbGpZ VyBkdkxDQk piR3hwIGJt OXBjeTQ4WW 4gSStOQzRn VkdobCBJR0 52YlhCaGJu IGtnWlcxd2 JHOTUgY3lC dmRtVnlJRC BRM0xEQXdN Q0J3IFpXOX diR1VnZDIg OXliR1IzYV dSbCBJR0Z1 WkNCb1lYIE 1nWVNCd2Nt VnogWlc1al pTQnBiaSBC dGIzSmxJSF JvIFlXNGdN VGN3SUcgTn ZkVzUwY21s bCBjeTQ4WW 5JK05TIDRn UVdKaVZtbG wgNG9DWmN5 QndjbSBsdF lYSjVJR1p2 IFkzVnpJR2 x6SUcgOXVJ R1JsZG1Wcy BiM0JwYm1j Z1lXIDVrSU cxaGJuVm0g WVdOMGRYSn BibSBjZ2NH aGhjbTFoIF kyVjFkR2xq WVcgd2djSE p2WkhWaiBk SE1nYVc0Z2 RHIGhsSUdG eVpXRnogSU c5bUlHbHRi WCBWdWIyeH ZaM2tzIElH OXVZMjlzYj IgZDVMQ0J1 WlhWeSBiM0 5qYVdWdVky IFVzSUhacG NtOXMgYjJk NUxDQmhibS BRZ1oyVnVa WEpoIGJDQn RaV1JwWTIg bHVaUzQ4WW 5JKyBOaTRn VkdobElHIE 52YlhCaGJu bmkgZ0psek lIUnZjQyAx elpXeHNhVz VuIElHUnlk V2NnYVggTW dTSFZ0YVhK aCBMQ0JoSU cxbFpHIGxq WVhScGIyNG cgZFhObFpD QjBieSBCMG NtVmhkQ0Jo IGRYUnZhVz F0ZFcgNWxJ R1JwYzI5eS BaR1Z5Y3lC emRXIE5vSU dGeklISm8g WlhWdFlYUn ZhVyBRZ1lY SjBhSEpwIG RHbHpMQ0J3 YzIgOXlhV0 Z6YVhNcyBJ R0Z1WkNCRG NtIDlvYnVL QW1YTWcgWk dselpXRnpa UyA0OFluSS tOeTRnIFFX SmlWbWxsSU cgaGhjeUJ0 WVdSbCBJSE 5wWjI1cFpt IGxqWVc1ME lHbHUgZG1W emRHMWxibi BSeklHbHVJ SFJvIFpTQm 1hV1ZzWkMg QnZaaUJpYV c5MCBaV05v Ym05c2IyIG Q1TENCd1lY SjAgYVdOMW JHRnliSCBr Z2FXNGdkR2 hsIElHRnla V0Z6SUcgOW 1JR05oYm1O bCBjaUJoYm 1RZ2FXIDF0 ZFc1dmJHOW 4gZVN3Z2RH aHliMyBWbm FDQndZWEow IGJtVnljMm hwY0ggTWdZ VzVrSUdGai BjWFZwYzJs MGFXIDl1Y3 k0OFluSSsg T0M0Z1NXNG dNaiBBeE9T d2dRV0ppIF ZtbGxJR052 YlggQnNaWF JsWkNCaCBJ Q1EyTXlCaW FXIHhzYVc5 dUlHRmogY1 hWcGMybDBh VyA5dUlHOW 1JRUZzIGJH VnlaMkZ1TE MgQmhJR2Rz YjJKaCBiQ0 J3YUdGeWJX IEZqWlhWMG FXTmggYkNC amIyMXdZVy A1NUlHdHVi M2R1IElHWn ZjaUJwZEgg TWdRbTkwYj NnZyBZbkpo Ym1RdVBHIE p5UGprdUlF RmkgWWxacF pTQm9ZWCBN Z1lTQnpkSE p2IGJtY2dZ Mjl0YlcgbD BiV1Z1ZENC MCBieUJ6ZF hOMFlXIGx1 WVdKcGJHbD AgZVNCaGJt UWdhRyBGek lHSmxaVzRn IGNtVmpiMm R1YVggcGxa Q0JtYjNJZy BhWFJ6SUdW bVptIDl5ZE hNZ2FXNGcg Y21Wa2RXTn BibSBjZ2FY UnpJR1Z1IG RtbHliMjV0 WlcgNTBZV3 dnYVcxdyBZ V04wSUhSb2 NtIDkxWjJn Z2FXNXAgZE dsaGRHbDJa WCBNZ2MzVm phQ0JoIGN5 QjFjMmx1Wn kgQnlaVzVs ZDJGaSBiR1 VnWlc1bGNt IGQ1SUdGdV pDQnkgWldS MVkybHVaeS BCM1lYUmxj aUJqIGIyNX pkVzF3ZEcg bHZiaTQ4WW 5JKyBNVEF1 SUZSb1pTIE JqYjIxd1lX NTUgSUdoaG N5QmhJRyBo cGMzUnZjbm tnIGIyWWdj R2hwYkcgRn VkR2h5YjNC NSBJR0Z1Wk NCb1lYIE1n Wkc5dVlYUm wgWkNCdGFX eHNhVyA5dW N5QnZaaUJr IGIyeHNZWE p6SUggUnZJ SFpoY21sdi BkWE1nWTJG MWMyIFZ6SU dGdVpDQnYg Y21kaGJtbD ZZWCBScGIy NXpMQ0JwIG JtTnNkV1Jw Ym0gY2dkR2 h2YzJVZyBa bTlqZFhObF pDIEJ2YmlC b1pXRnMgZE dnZ1kyRnla UyB3Z1pXUj FZMkYwIGFX OXVMQ0JoYm 0gUWdjbVZt ZFdkbCBaU0 JoYzNOcGMz IFJoYm1ObE xnPT0KICAg ICAgICA8L3 NwYW4+CiAg ICAgICAgCi AgICAgICAg
See Company Q&A
AbbVie

πŸ“Š Get full analytics about AbbVie

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal